Assignee
REGENERON PHARMACEUTICALS INC
US·2 granted patents·3 pending applications·0 citations·filing 2017–2025
Top patents by PatentIndex Score
5 records- 0177US2026097102A1Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) InhibitorsREGENERON PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0260US2026098084A1Anti-tmprss6 antibodies and uses thereofREGENERON PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0359US12594337B2Human serum albumin in formulationsREGENERON PHARMACEUTICALS INC·Filed 2021·Granted Apr 7, 2026·0 cites·14 claims
- 0454US2026097063A1Anti-c5 antibody/c5 irna dosing regimens for treating c5-associated diseasesREGENERON PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0541US12594350B2CD8-specific capture agents, compositions, and methods of using and makingREGENERON PHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2026·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when REGENERON PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →